Primer group for rapid detection of 2019-nCoV based on CRISPR technology and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 广州微远医疗器械有限公司
- Publication Date
- 2020-07-03
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of genetic detection based on CRISPR technology, in particular to a primer set for rapid detection of 2019-nCoV based on CRISPR technology and its application. Background technique
[0002] Coronaviruses are a large class of RNA viruses. There are currently seven known coronaviruses that can infect humans. Four of these coronaviruses, including Human coronavirus 229E, Human coronavirus OC43, Human coronavirus NL63, and Human coronavirus HKU1, are more common in the population, but are less pathogenic and generally only cause mild respiratory syndrome similar to the common cold. Two other viruses, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS), can cause severe respiratory illness. 2019-nCoV is the seventh human-infecting coronavirus discovered so far.
[0003] 2019-nCoV is a betacoronavirus similar to MERS and SARS, both of which originated in bats. The in...